Andere Sprachen Renovaro Inc. Börse Stuttgart

Aktien

A2PBYQ

US29350E1047

2Q5

Verzögert Börse Stuttgart Andere Börsenplätze 08:13:41 01.07.2024			% 5 Tage	% 1. Jan.
1.592 ^EUR	+16.89%		+11.09%	-49.30%

14.06.	Renovaro: Investoren sagen $10 Millionen zusätzliches Eigenkapital zu	MT
24.05.	Renovaro und das Amsterdam UMC Cancer Center planen die Gründung eines Joint Ventures für Krebsimmuntherapie	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Renovaro Says Investors Commit $10 Million Additional Equity	14.06.
Renovaro, Inc. Announces $10 million in Equity Committed	14.06.
Renovaro Inc. announced that it has received $9.455942 million in funding	14.06.
Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy	24.05.
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	24.05.
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy	24.05.
Renovaro Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	15.05.
Renovaro : Material Event - Form 8-K	02.05.
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30.04.
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics	30.04.
RENOVARO - RENOVAROCUBE TO ACQUIRE 100% OWNERSHIP OF CYCLOMICS, REINFORCING CUTTING-EDGE CANCER DIAGNOSTICS PARTNERSHIP	25.04.
Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics	24.04.
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership	24.04.
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care	18.04.
Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board	18.04.
Renovaro Inc. Appoints Simon Tarsh as Interim Chief Financial Officer	13.03.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	12.03.
Renovaro Inc. Announces Resignation of Luisa Puche as Chief Financial Officer, Effective as of March 21, 2024	05.03.
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB	03.03.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB	25.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Renovaro Inc. Börse Stuttgart

Aktien

A2PBYQ

US29350E1047

2Q5

Andere Sprachen

Filter